AstraZeneca e Bristol Myers mantiveram conversas sobre fusão, informa Financial Times (AZN:NYSE)
· seekingalpha.com
AstraZeneca e Bristol Myers Squibb mantiveram conversas preliminares sobre fusão, segundo o FT.
AstraZeneca (AZN) and Bristol Myers Squibb (BMY) have held preliminary discussions about a potential combination that would create one of the world's largest ph...